Skip to Content
Merck
CN
  • A rare sugar xylitol. Part II: biotechnological production and future applications of xylitol.

A rare sugar xylitol. Part II: biotechnological production and future applications of xylitol.

Applied microbiology and biotechnology (2007-01-12)
Tom Birger Granström, Ken Izumori, Matti Leisola
ABSTRACT

Xylitol is the first rare sugar that has global markets. It has beneficial health properties and represents an alternative to current conventional sweeteners. Industrially, xylitol is produced by chemical hydrogenation of D-xylose into xylitol. The biotechnological method of producing xylitol by metabolically engineered yeasts, Saccharomyces cerevisiae or Candida, has been studied as an alternative to the chemical method. Due to the industrial scale of production, xylitol serves as an inexpensive starting material for the production of other rare sugars. The second part of this mini-review on xylitol will look more closely at the biotechnological production and future applications of the rare sugar, xylitol.

MATERIALS
Product Number
Brand
Product Description

Xylitol, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Xylitol, ≥99% (GC)
Sigma-Aldrich
Xylitol
Supelco
Xylitol, Pharmaceutical Secondary Standard; Certified Reference Material